These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23783455)

  • 1. Synthesis and radiolabelling of DOTA-linked glutamine analogues with ⁶⁷,⁶⁸Ga as markers for increased glutamine metabolism in tumour cells.
    Pellegrini PA; Howell NR; Shepherd RK; Lengkeek NA; Oehlke E; Katsifis AG; Greguric I
    Molecules; 2013 Jun; 18(6):7160-78. PubMed ID: 23783455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioorthogonal chemistry for (68) Ga radiolabelling of DOTA-containing compounds.
    Evans HL; Carroll L; Aboagye EO; Spivey AC
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):291-7. PubMed ID: 24307493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies.
    Orteca G; Pisaneschi F; Rubagotti S; Liu TW; Biagiotti G; Piwnica-Worms D; Iori M; Capponi PC; Ferrari E; Asti M
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
    Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
    J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers.
    Jussing E; Milton S; Samén E; Moein MM; Bylund L; Axelsson R; Siikanen J; Tran TA
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
    Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
    Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking cyclotron
    Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
    Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
    Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.
    Mueller D; Klette I; Baum RP; Gottschaldt M; Schultz MK; Breeman WA
    Bioconjug Chem; 2012 Aug; 23(8):1712-7. PubMed ID: 22755505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga 'vacuum elution approach' for direct radiolabelling of DOTA-conjugated and NODAGA-conjugated peptides.
    Ben Azzouna R; Leygnac S; Al-Shoukr F; Rouzet F; Guilloteau D; Le Guludec D
    Nucl Med Commun; 2017 Jan; 38(1):51-56. PubMed ID: 27824725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography.
    Shetty D; Jeong JM; Ju CH; Kim YJ; Lee JY; Lee YS; Lee DS; Chung JK; Lee MC
    Bioorg Med Chem; 2010 Nov; 18(21):7338-47. PubMed ID: 20926300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the radiosynthesis of [
    Ghai A; Singh B; Li M; Daniels TA; Coelho R; Orcutt K; Watkins GL; Norenberg JP; Cvet D; Schultz MK
    Appl Radiat Isot; 2018 Oct; 140():333-341. PubMed ID: 30138815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
    de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
    Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.